Zenas Biopharma, Inc. - ZBIO Net Assets per Single Share

Graphic logo of Zenas Biopharma Inc (ZBIO)

The Zenas Biopharma Inc (ZBIO) price chart reflects the dynamics of an ambitious brand developing cutting-edge treatments for autoimmune pathologies. The current figure stands at 3.88, while management strictly monitors expenditures on clinical trials for anti-inflammatory drugs. High barriers to entry and patent protection for unique antibodies provide Zenas Biopharma Inc (ZBIO) with a sustainable competitive advantage in the biologics market.

Zenas Bio (ZBIO): Share Book Value from 09/14/2024 to 10/28/2026

zenasbio.com - analytical breakdowns and key metrics (ZBIO)

- price and consensus price forecast:
Stock Price Zenas Biopharma, Inc.|ZBIO - Analyst Median Target
- market capitalization data:
Market Value Zenas Biopharma Inc|ZBIO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Zenas Biopharma|ZBIO - Net Asset Value|Market Capitalization to Book Value Ratio zenasbio.com|ZBIO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Zenas Biopharma Inc|ZBIO - Long-Term Debt to Capital|Short-Term Debt to Equity Zenas Biopharma|ZBIO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Zenas Biopharma Inc|ZBIO - Company Long-Term Liabilities|Company Short-Term Debts Zenas Biopharma
Fundamental company valuation:Zenas Biopharma, Inc. - ZBIO
Manufactured products of Zenas Biopharma

The investor is seeking an objective balance between asset value and the market valuation of Zenas Biopharma Inc (ZBIO). This indicator determines the portion of net equity per share after deducting all liabilities. For a biotechnology startup in the clinical trial stage, this serves as a measure of the actual resource backing for drug development. The absence of market pricing makes capital the key guarantee of survival. The trend in the calculated book value per share reflects the pace of business scaling.

Competitors of Zenas Biopharma Inc (ZBIO)

Book Value per Share ARGX (Argenx)|BNTX: Net Assets per Share|Net Assets per Single Share ABVX|ADMA (admabiologics.com) - Net Asset Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|ATXS - Net Asset Value per Share|Accounting Value per Share enGene Bio|RAPT - Share Book Value|Book Value per Share JBIO|ACRS (aclaristx.com) - Net Asset Value per Share|Net Assets per Single Share Kyverna Therapeutics, Inc. (KYTX)|Equity per Share Tiziana Life Sciences Ltd.|Book Value per Share CABA|Book Value per Share VTYX (Ventyx Biosciences, Inc)|Net Assets per Single Share THTX|AVTX - Net Assets per Share|Accounting Value per Share Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Accounting Value of a Share|Climb Bio, Inc. (CLYM) - Book Value per Share|Zura Bio Ltd (ZURA) - Net Assets per Single Share|ATYR: Book Value per Share|Net Assets per Share ADAG|ImageneBio Inc - Net Assets per Single Share|Net Asset Value per Share STTK (shattucklabs.com)|Equillium (EQ) - Net Assets per Single Share|Share Book Value Connect Biopharma Holdings CNTB|Book Value per Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|IFRX: Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Book Value per Share|ACET - Net Assets per Single Share|Accounting Value of a Share CELU|Net Assets per Single Share INMB (INmune Bio, Inc.)|Accounting Value per Share barinthusbio.com (BRNS)|Book Value per Share KZR (Kezar Life Sciences, Inc.)|SABS - Book Value per Share|Accounting Value per Share Akari Therapeutics plc (AKTX)|ENLV - Accounting Value of a Share|q32bio.com - Book Value per Share|GOVX (geovax.com) - Net Assets per Share|Net Assets per Single Share Edesa Biotech (EDSA)|Equity per Share iBio Inc|Book Value per Share CARM (Carisma Therapeutics)|Accounting Value per Share XTL Bio XTLB|Bolt Biotherapeutics, Inc. (BOLT) - Accounting Value per Share|Share Book Value HCW Biologics, Inc. HCWB|APVO - Book Value per Share|AIM - Net Assets per Single Share|aditxt.com - Book Value per Share|GRI (GRI Bio Corporation) - Net Assets per Share|Net Assets per Single Share XRTX (XORTX Therapeutics Inc.)|Net Asset Value per Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD